Lisata Therapeutics, Inc.
LSTA
$2.28
$0.00010.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.19% | 3.72% | 4.10% | 3.38% | 60.68% |
| Total Depreciation and Amortization | -8.11% | -8.56% | -7.94% | -4.76% | 23.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.46% | 45.58% | 22.85% | -18.66% | -97.69% |
| Change in Net Operating Assets | 376.16% | -128.13% | -88.96% | 128.14% | 108.46% |
| Cash from Operations | 17.82% | 6.00% | 3.37% | 15.75% | 12.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.55% | 32.71% | 30.99% | -73.29% | 51.44% |
| Cash from Investing | -79.67% | 32.48% | 30.99% | -73.26% | 90.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 489.29% | -39.50% | -85.71% | -87.98% | -87.98% |
| Repurchase of Common Stock | -160.14% | -153.38% | -201.10% | -56.04% | 19.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40.22% | -126.52% | -153.51% | -122.93% | -132.62% |
| Foreign Exchange rate Adjustments | 36.67% | 103.13% | -243.75% | -178.57% | -20.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -348.92% | 74.99% | 33.23% | -1,459.89% | 147.66% |